SelectScience InterviewsClinical Diagnostics

CLINICAL24: Challenges, collaborations, and innovations in hematology

21 Oct 2024
CLINICAL24: Challenges, collaborations, and innovations in hematology

Leadership perspectives: Andy Hay, President of Sysmex America Ltd., in discussion with Sonia Nicholas, SelectScience, discusses critical challenges facing laboratories, including staffing shortages, consolidation, and declining reimbursements. Plus, while COVID-19 briefly highlighted medical technology, it quickly faded from public focus. To overcome these hurdles, companies like Sysmex are focusing on automation, AI, and partnerships to improve care. A new frontier in neurology, especially in detecting diseases like Alzheimer's, is emerging. Hay believes that the industry's future lies in cross-functional collaborations and a balance between profitability and meaningful impact on patient care, aiming to shift from reactive to proactive healthcare.

This interview was recorded for #CLINICAL24 2024

Tags

HematologyIn Haematology / Hematology, complete blood cell counts (or full blood counts) are obtained using automated blood count analyzers to enumerate blood cell types.  Hematology also encompasses haemostasis and coagulation, thrombophilia and hemophilia, plasma viscosity and ESR analysis, hemoglobinopathies, cell morphology and haematinic measurement.CLINICAL24CLINICAL24 is a global conversation, hosted by SelectScience for the medical laboratory profession and all those that support it. The purpose of CLINICAL24 is to highlight current lab challenges, and to explore the technology solutions to overcome them. Alzheimers Disease
Exclusive interview with Andy Hay Sysmex America on challenges in hematology